Efficacy and safety of daclatasvir-containing regimens in the treatment of chronic hepatitis C patients in Damietta

Efficacy and safety of daclatasvir-containing regimens in the treatment of chronic hepatitis C patients in Damietta

Background Chronic hepatitis C virus infection is one of the most important health problems in Egypt. Since November 2015, generic sofosbuvir (SOF) with daclatasvir (DCV)±ribavirin (RBV) became the standard treatment in all National Committee for Control of Viral Hepatitis centers. Yet, the long-ter...

Full description

Bibliographic Details
Main Authors: Alaa Eldeen M Hashim, Samy Zaky, Magdy Z Alghannam, Sabry A Ibraheem, Fathiya M El-Raey, Ahmed Abdelaziz
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Al-Azhar Assiut Medical Journal
Subjects:
daclatasvir
direct acting antivirals
hcv
hepatitis c virus
treatment safety
Online Access:http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2020;volume=18;issue=2;spage=159;epage=167;aulast=

Internet

http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2020;volume=18;issue=2;spage=159;epage=167;aulast=

Similar Items